Cargando…

SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma

Objective: Glioma is the most common primary malignancy of the adult central nervous system (CNS), with a poor prognosis and no effective prognostic signature. Since late 2019, the world has been affected by the rapid spread of SARS-CoV-2 infection. Research on SARS-CoV-2 is flourishing; however, it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Fan, Lu, Deng-Feng, Zhan, Zheng, Yuan, Gui-Qiang, Liu, Guang-Jie, Gu, Jing-Yu, Sun, Xiao-Ou, Wang, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777143/ https://www.ncbi.nlm.nih.gov/pubmed/36552760 http://dx.doi.org/10.3390/cells11243997

Ejemplares similares

A gene expression-based study on immune cell subtypes and glioma prognosis
por: Zhong, Qiu-Yue, et al.
Publicado: (2019)

The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma
por: Han, Xu, et al.
Publicado: (2023)

Necroptosis‐related regulatory pattern and scoring system for predicting therapeutic efficacy and prognosis in ovarian cancer
por: Lai, Huiling, et al.
Publicado: (2023)

Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
por: Jiang, Fan, et al.
Publicado: (2022)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

A GLO10 score for the prediction of prognosis in high grade gliomas
por: Chen, Feng, et al.
Publicado: (2017)

Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets
por: Codrici, Elena, et al.
Publicado: (2016)

Clinical characteristics, treatment and prognosis of angiocentric glioma
por: Han, Guoqing, et al.
Publicado: (2020)

SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications
por: Abou Hassan, Ossama K., et al.
Publicado: (2021)

A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma
por: Fan, Wenhua, et al.
Publicado: (2022)

Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients
por: Yang, Chen, et al.
Publicado: (2023)

Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma
por: Shi, Bo, et al.
Publicado: (2023)

Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation
por: Tang, Qian, et al.
Publicado: (2021)

SCAMP3 Promotes Glioma Proliferation and Indicates Unfavorable Prognosis via Multiple Pathways
por: Li, Chunliu, et al.
Publicado: (2020)

Peripheral blood test provides a practical method for glioma evaluation and prognosis prediction
por: Wang, Zhi‐Liang, et al.
Publicado: (2019)

TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma
por: Li, Shasha, et al.
Publicado: (2023)

Exploring the Role of microRNAs in Glioma Progression, Prognosis, and Therapeutic Strategies
por: Tluli, Omar, et al.
Publicado: (2023)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

Circadian Regulation Patterns With Distinct Immune Landscapes in Gliomas Aid in the Development of a Risk Model to Predict Prognosis and Therapeutic Response
por: Tian, Ruotong, et al.
Publicado: (2022)

Comprehensive analysis of pyroptosis regulation patterns and their influence on tumor immune microenvironment and patient prognosis in glioma
por: Fan, Tianyu, et al.
Publicado: (2022)

Smoothened is a poor prognosis factor and a potential therapeutic target in glioma
por: Tu, Yiming, et al.
Publicado: (2017)

Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas
por: Li, Mingxiao, et al.
Publicado: (2022)

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma
por: Liu, Hanzhang, et al.
Publicado: (2022)

TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion
por: Li, Bin, et al.
Publicado: (2015)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy
por: Li, Ganglei, et al.
Publicado: (2021)

Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2
por: Fan, Shiyong, et al.
Publicado: (2020)

A Novel Scoring System Based on Peripheral Blood Test in Predicting Grade and Prognosis of Patients with Glioma
por: Wu, Yiyang, et al.
Publicado: (2019)

Generation and Characterization of a Nanobody Against SARS-CoV
por: Li, Jiang-Fan, et al.
Publicado: (2021)

Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
por: Li, Jing, et al.
Publicado: (2020)

Erratum: TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion
por: Li, Bin, et al.
Publicado: (2015)

Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas
por: Zhao, Wei-jiang, et al.
Publicado: (2021)

Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021)

Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma
por: Liu, Pei, et al.
Publicado: (2020)

Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma
por: Zhou, Zhengui, et al.
Publicado: (2018)

Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas
por: Penman, Catherine Louise, et al.
Publicado: (2015)

Interfering with CALCRL expression inhibits glioma proliferation, promotes apoptosis, and predicts prognosis in low-grade gliomas
por: Gu, Shengcai, et al.
Publicado: (2022)

Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma
por: Shi, Junfeng, et al.
Publicado: (2022)

A Novel Mitochondrial-Related Gene Signature for the Tumor Immune Microenvironment Evaluation and Prognosis Prediction in Lung Adenocarcinoma
por: Li, Yin-ping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pjssfdq4n232d5vs159ao6ng7o